UNSPSC 51182057: Nandrolone cyclotate

This classification denotes a therapeutic androgen and anabolic steroid C28H38O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1MG9GW4ZH8, chemically known as estr-4-en-3-one, 17-(((4-methylbicyclo(2.2.2)oct-2-en-1-yl)carbonyl)oxy)-, (17.beta.)-, but more generally known as nandrolone cyclotate, which bears US NIH Compound Identifier 164526. Most nations, for tariff and trade purposes, schedule nandrolone cyclotate under HS 29372900 and SITC 54153. As of Q4 2014, NANDROLONE CYCLOTATE remains US FDA's Preferred Term for this commodity.

Nandrolone cyclotate bears US NLM identifiers UMLS ID C2828223 and NCI Concept Code C87228. SMILES: C[C@@]12C=C[C@@](CC1)(CC2)C(=O)O[C@@H]3[C@@]4([C@H]([C@H]5[C@@H]([C@@H]6C(=CC(=O)CC6)CC5)CC4)CC3)C.

UNSPSC 51182057 Nandrolone cyclotate is a Commodity code representing a synthetic anabolic steroid pharmaceutical product. State and local procurement activity under this code is minimal to nonexistent. The code's nominal scope — a controlled pharmaceutical compound — does not align with typical state and local government purchasing patterns, which center on commonly procured items such as office supplies, facility maintenance, fleet vehicles, construction services, and standard medical supplies rather than specialty pharmaceutical compounds.

No recent state and local contract opportunities under this code are present in the available record. The code appears dormant or rarely applied in state and local procurement workflows.